Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Nguyen

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National AnalysisLucia Parlati, Charlotte Mouliade, Eric Nguyen Khac, et al.
Oncotarget|January 23, 2016
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferationHicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, et al.
Oncotarget|April 16, 2016
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugsGrégory Fouquet, Véronique Debuysscher, Hakim Ouled-Haddou, et al.
The New England Journal of Medicine|November 11, 2011
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitisEric Nguyen-Khac, Thierry Thevenot, Marie-Astrid Piquet, et al.
Digestive Diseases and Sciences|September 24, 2016
Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based StudyMathurin Fumery, Mathieu Kohut, Corinne Gower-Rousseau, et al.
Molecular Cancer Research : MCR|July 22, 2010
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.
Cancer Biology & Therapy|September 10, 2009
Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French studyEric Nguyen-Khac, Isabelle Ollivier, Thomas Aparicio, et al.
Clinical and Translational Gastroenterology|September 4, 2019
Long-Term Natural History of Microscopic Colitis: A Population-Based CohortJulien Loreau, Dana Duricova, Corinne Gower-Rousseau, et al.
World Journal of Hepatology|April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatientsJean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Radiology|May 1, 2019
Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II TrialBoris Guiu, Patrick Chevallier, Eric Assenat, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival: A National AnalysisLucia Parlati, Charlotte Mouliade, Eric Nguyen Khac, et al.
Oncotarget|January 23, 2016
RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferationHicham Bouhlal, Hakim Ouled-Haddou, Véronique Debuysscher, et al.
Oncotarget|April 16, 2016
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugsGrégory Fouquet, Véronique Debuysscher, Hakim Ouled-Haddou, et al.
The New England Journal of Medicine|November 11, 2011
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitisEric Nguyen-Khac, Thierry Thevenot, Marie-Astrid Piquet, et al.
Digestive Diseases and Sciences|September 24, 2016
Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based StudyMathurin Fumery, Mathieu Kohut, Corinne Gower-Rousseau, et al.
Molecular Cancer Research : MCR|July 22, 2010
BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinomaAntoine Galmiche, Zakaria Ezzoukhry, Catherine François, et al.
Cancer Biology & Therapy|September 10, 2009
Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French studyEric Nguyen-Khac, Isabelle Ollivier, Thomas Aparicio, et al.
Clinical and Translational Gastroenterology|September 4, 2019
Long-Term Natural History of Microscopic Colitis: A Population-Based CohortJulien Loreau, Dana Duricova, Corinne Gower-Rousseau, et al.
World Journal of Hepatology|April 5, 2013
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatientsJean-François Cadranel, Jean-Baptiste Nousbaum, Christophe Bessaguet, et al.
Radiology|May 1, 2019
Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II TrialBoris Guiu, Patrick Chevallier, Eric Assenat, et al.
Pageof 15